Last week, RenBio’s Dr. Rachel Liberatore and Dr. Linda Sasset attended the ASGCT 27th Annual Meeting in Baltimore. It was an honor to be in attendance, where we connected with fellow innovators and leaders in the field of gene and cell therapy.

Dr. Sasset’s abstract, titled “Next-Generation DNA-Based Delivery of Therapeutic Proteins Using MYO Technology: Preclinical Results on Incretins Receptor Agonists,” garnered significant interest and sparked engaging discussions.

Thank you to everyone who attended and contributed to the vibrant exchange of ideas. If you missed it, you can now view Dr. Sasset’s poster (#1741) here.


We are grateful for the opportunity to share our work and look forward to future collaborations.

Stay tuned for more updates as we continue to advance our research in biotechnology.